October 5, 2010
by peter.taylor
2 Comments
How does the new trolley scenario (see previous post) provide a different angle to approach the incommensurability of the individual experience and the net social benefit? (The need for a new angle arose because allocation of health care funds according … Continue reading
October 4, 2010
by peter.taylor
2 Comments
Allocation of health care funds according to benefit/cost calculations (see previous post) cannot be expected to satisfy the person with the story about screening saving their life. Is there a different angle to approach the incommensurability of the individual experience … Continue reading
October 2, 2010
by peter.taylor
2 Comments
Personal stories of the kind, “I would not be alive if a routine screening mammogram had not detected my breast cancer,” dominate the letters to the editor after any news of research or policy proposals that favor less use of … Continue reading
September 21, 2010
by peter.taylor
0 comments
For a gene in which the effect depends on the environmental condition, what kinds of medical conditions would receive the necessary investment in pharmaceutical and sociological research, screening, and preventative treatment/monitoring to address the conjunction of genetic and environmental factors … Continue reading